Why the Covid surge in China is unlikely to pose a big risk to other countries

In contrast to China at the outset of this wave, most nations by now have high immunity and protection against severe disease and death from Covid.

Paul Hunter, The Conversation

· Jan 11, 2023 · 09:30 pm

Ancient germs are escaping the melting Arctic. How worried should we be?

A Pandoravirus has been revived after remaining dormant in the Siberian permafrost for nearly 50,000 years.

Paul Hunter, The Conversation

· Dec 08, 2022 · 11:30 pm

Why are Covid-19 cases surging in some countries, but not in others?

New Zealand, Hong Kong and South Korea, which had stayed fairly Covid-free, are seeing huge spikes in coronavirus cases.

Paul Hunter, The Conversation

· Apr 02, 2022 · 11:30 pm

Are Covid-19 reinfections milder and do they affect immunity?

A single, prior infection gives similar protection against infection with Omicron as two doses of vaccine.

Paul Hunter, The Conversation

· Feb 15, 2022 · 07:30 pm

Why Omicron appears to cause milder illness than earlier variants

Analysis by the UK Health Security Agency suggests that the new variant is only about a third as likely to lead to hospital admission compared to Delta.

Paul Hunter, The Conversation

· Jan 10, 2022 · 09:30 pm

Covid-19: Peer-reviewed report shows Oxford vaccine is safe – but how effective is it?

The most challenging issue with the vaccine trial is that it has pooled analysis of the vaccine’s efficacy from three separate trials.

Paul Hunter, The Conversation

· Dec 11, 2020 · 09:30 pm